CancerSCEM 2.0: an updated data resource of single-cell expression map across various human cancers
Nucleic Acids Research · 06.01.2025 · 53 (D1) · D1278-D1286
DOI: 10.1093/nar/gkae954 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 26.10.2024. Verfasst von Jingyao Zeng und 9 weiteren Autor:innen. Beteiligte Einrichtung: National Genomics Data Center, China National Center for Bioinformation, Beijing 100101, China. Hauptthemen laut MEDLINE: Single-Cell Analysis, Neoplasms. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Youth Innovation Promotion Association of the Chinese Academy of Sciences, Chinese Academy of Sciences, National Natural Science Foundation of China.
Abstract (Originalsprache)
The field of single-cell RNA sequencing (scRNA-seq) has advanced rapidly in the past decade, generating significant amounts of valuable data for researchers to study complex tumor profiles. This data is crucial for gaining innovative insights into cancer biology. CancerSCEM (https://ngdc.cncb.ac.cn/cancerscem) is a public resource that integrates, analyzes and visualizes scRNA-seq data related to cancer, and it provides invaluable support to numerous cancer-related studies. With CancerSCEM 2.0, scRNA-seq data have increased from 208 to 1466 datasets, covering tumor, matching-normal and peripheral blood samples across 127 research projects and 74 cancer types. The new version of this resource enhances transcriptome analysis by adding copy number variation evaluation, transcription factor enrichment, pseudotime trajectory construction, and diverse biological feature scoring. It also introduces a new cancer metabolic map at the single-cell level, providing an intuitive understanding of metabolic regulation across different cancer types. CancerSCEM 2.0 has a more interactive analysis platform, including four modules and 14 analytical functions, allowing researchers to perform cancer scRNA-seq data analyses in various dimensions. These enhancements are expected to expand the usability of CancerSCEM 2.0 to a broader range of cancer research and clinical applications, potentially revolutionizing our understanding of cancer mechanisms and treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- National Genomics Data Center, China National Center for Bioinformation, Beijing 100101, China.
- Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100101, China.
- University of Chinese Academy of Sciences, Beijing 100049, China.
- Huazhong University of Science and Technology, Wuhan 430074, China.
ORCID-Profile: Jingyao Zeng, Yadong Zhang, Jingfa Xiao
Förderung
- Youth Innovation Promotion Association of the Chinese Academy of Sciences
- Chinese Academy of Sciences
- National Natural Science Foundation of China
Zitieren
APA
Zeng, J., Nie, Z., Shang, Y., Mai, J., Zhang, Y., Yang, Y., Xu, C., Zhao, J., Fan, Z., & Xiao, J. (2025). CancerSCEM 2.0: an updated data resource of single-cell expression map across various human cancers. Nucleic Acids Research, 53(D1), D1278-D1286. https://doi.org/10.1093/nar/gkae954
Vancouver
Zeng J, Nie Z, Shang Y, Mai J, Zhang Y, Yang Y, et al. CancerSCEM 2.0: an updated data resource of single-cell expression map across various human cancers. Nucleic Acids Research. 2025;53(D1):D1278-D1286. doi:10.1093/nar/gkae954
BibTeX
@article{Zeng2025,
author = {Zeng, Jingyao and Nie, Zhi and Shang, Yunfei and Mai, Jialin and Zhang, Yadong and Yang, Yuntian and Xu, Chenle and Zhao, Jing and Fan, Zhuojing and Xiao, Jingfa},
title = {CancerSCEM 2.0: an updated data resource of single-cell expression map across various human cancers},
journal = {Nucleic Acids Research},
year = {2025},
volume = {53},
number = {D1},
pages = {D1278--D1286},
doi = {10.1093/nar/gkae954}
}
EUVIMED